Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.
Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.
复制标题
DOI:
10.1161/atvbaha.110.213280
复制
发表时间:
2010-11
期刊:
影响因子:
--
通讯作者:
Pawlinski R
中科院分区:
文献类型:
--
作者:
Antoniak S;Rojas M;Spring D;Bullard TA;Verrier ED;Blaxall BC;Mackman N;Pawlinski R
Protease-activated receptor-2 (PAR-2) signaling enhances inflammation in different diseases. The effect of PAR-2 deficiency in cardiac ischemia/reperfusion (I/R) injury is unknown. We investigated the effect of PAR-2 deficiency on I/R injury-induced infarct size, inflammation, heart remodeling and cardiac function. PAR-−/−- mice and wild-type (WT) littermates were subjected to 30 minutes of ischemia and up to 4 weeks of reperfusion. Infarct size, oxidative/nitrative stress, phosphorylation of mitogen-activated protein kinases (MAPK) and inflammatory gene expression were assessed 2 hours after reperfusion. Changes in heart size and function were measured by echocardiography up to 4 weeks after reperfusion. Infarct size was significantly reduced in hearts of PAR-2−/− mice compared to WT littermates. In addition, oxidative/nitrative stress, phosphorylation of MAPK and expression of pro-inflammatory genes were significantly attenuated in injured hearts of PAR-2−/− mice. Finally, PAR-2−/− mice were protected from post-infarction remodeling and showed less impairment in heart function compared with WT littermates up to 4 weeks after I/R injury. PAR-2 deficiency reduces myocardial infarction and heart remodeling following I/R injury.